Topical r-Hirudin ( Thrombexx ) Efficacy in Treatment of Haematomas

NCT01960569 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

r-Hirudin (Thrombexx) Efficacy in Treatment of Haematomas

Interventions

DRUG: active product ( Thrombexx) assigned to arm 1
OTHER: Placebo assigned to arm 2

Sponsor

MinaPharm Pharmaceuticals